Prostate cancer news reports: Tuesday, May 19, 2009

Today’s reports address:

  • How German prostate cancer specialists would treat themselves
  • Identification of patients appropriate for focal therapy
  • Italian management of men with an elevated PSA level
  • Triple therapy for men with T3a,b disease

Based on data from Gillitzer et al., it seems that the training of German urologists and radiation oncologists seems to affect their attitudes to treatment of localized prostate cancer in the same manner as it affects their American counterparts.

Mouraviev et al. have offered additional opinion on issues related to the identification of patients appropriate for focal therapy — a topic that continues to be controversial.

If we are interpreting the abstract of a paper by Leoni et al. correctly (and it is a little difficult to understand their abstract), they are suggesting that the management of men with an elevated PSA level in two Italian health districts is significantly more conservative than the management suggested by the data from the European Randomized Screening for Prostate Cancer (ERSPC) trial.

Schelin et al. have conducted a retrospective analysis of 98 Swedish patients with T3a,b disease treated with radical prostatectomy + external beam radiation + androgen deprivation therapy between 1995 and 2005. The mean observation time from initial surgery is 71.6 months and only 15/98 patients had biochemical failure after triple therapy. They conclude that triple therapy in this group of patients appears to offer a high potential for progression-free survival.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: